Literature DB >> 9459403

Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection.

G Elhanan1, M Sarhat, R Raz.   

Abstract

Recent data suggests that culture isolations and susceptibility profiles are overlooked, misinterpreted and are not a major determinant in the process of selecting anti-bacterial therapy. Compliance with empiric antibiotic protocols, relationship between blood culture results, change and selection of secondary antibiotic regimens and effect on outcome and length of hospitalization were assessed prospectively in 134 episodes of community-acquired bacteraemia due to urinary tract infection in adults. Empiric antibiotic protocols were correct in 112 episodes (83.6%), excessive in 12 episodes (8.95%) and inappropriate in 10 (7.5%) episodes, with no significant difference in outcome or length of hospitalization. Excluding early deaths, the adequacy of the initial antibiotic therapy was clearly associated with mortality (four deaths out of eight episodes treated incorrectly vs. 21/117 treated appropriately [P = 0.029]), but not with length of hospitalization. Antibiotic change was theoretically required in 92/119 (77.3%) episodes (27 [29.3] incorrect regimen, 65 [70.65%] excessive regimen), but actual change was made in only 43 episodes, of which three protocols were changed from a correct to an incorrect regimen, and one patient continued to receive an incorrect regimen. Eighteen out of 34 changes in excessive protocols were still excessive. Adequacy of secondary antibiotic treatment was clearly associated with outcome (5/10 vs. 4/109 [P<0.001]). Excessive protocols were not associated with better outcome or shorter hospital stay. Change of antibiotic regimen was associated with the presence of background diseases (5.6-fold increase) and inversely with hospitalization on the urology ward (0.254), but no independent factors associated with correct or incorrect secondary regimens could be identified. Although the compliance rate with empiric protocols was satisfactory, in many bacteraemic episodes blood culture results and antibiotic sensitivity profiles are overlooked, leading to higher mortality and excessive, unjustified use of expensive and broad-spectrum antibiotics. We could not identify factors associated with this disregard of susceptibility profiles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9459403     DOI: 10.1016/s0163-4453(97)93194-7

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  23 in total

1.  Influence of microbiological reports on physician's choice of antimicrobial treatment for susceptible pathogens.

Authors:  J Cobo; J Oliva; J Sanz; J M Aguado; Jose L Del Pozo; J del Pozo; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

Review 2.  [Urosepsis and treatment].

Authors:  F M E Wagenlehner; C Lichtenstern; M A Weigand; W Weidner
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

3.  Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): diverse and impactful.

Authors:  G Pongas; G Hamilos; K V Rolston; Dimitrios P Kontoyiannis
Journal:  Support Care Cancer       Date:  2010-12-30       Impact factor: 3.603

Review 4.  [The value of clinical infectology].

Authors:  M Battegay; U Flückiger
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

Review 5.  Epidemiology, treatment and prevention of healthcare-associated urinary tract infections.

Authors:  F M E Wagenlehner; Mete Cek; Kurt G Naber; Hiroshi Kiyota; Truls E Bjerklund-Johansen
Journal:  World J Urol       Date:  2011-09-07       Impact factor: 4.226

Review 6.  Reducing infection rates after prostate biopsy.

Authors:  Florian M E Wagenlehner; Adrian Pilatz; Przemyslaw Waliszewski; Wolfgang Weidner; Truls E Bjerklund Johansen
Journal:  Nat Rev Urol       Date:  2014-01-14       Impact factor: 14.432

Review 7.  Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.

Authors:  Florian M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  Use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection.

Authors:  D Raveh; B Rudensky; M Huerta; Y Aviv; A M Yinnon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-01       Impact factor: 3.267

9.  Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals.

Authors:  Jun Seong Son; Jae-Hoon Song; Kwan Soo Ko; Joon Sup Yeom; Hyun Kyun Ki; Shin-Woo Kim; Hyun-Ha Chang; Seong Yeol Ryu; Yeon-Sook Kim; Sook-In Jung; Sang Yop Shin; Hee Bok Oh; Yeong Seon Lee; Doo Ryeon Chung; Nam Yong Lee; Kyong Ran Peck
Journal:  J Korean Med Sci       Date:  2010-06-18       Impact factor: 2.153

10.  Approach to a patient with urosepsis.

Authors:  Om Prakash Kalra; Alpana Raizada
Journal:  J Glob Infect Dis       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.